In our study, it is bound to the P53 binding site CCCGGG (Yang & Festing, 2001) which protects the organism from the spread of an aberrant genetic signal (Jacobs et a., 2006) and is associated with neurological development and mental illnesses such as schizophrenia (Warburton et al., 2015). This evidence concerns the gene TP53 and schizophrenia.